cannabidiol + bio-terpene complex

Cannabidiol + bio-terpene complex is a combination drug containing **cannabidiol (CBD)**, a phytocannabinoid found in Cannabis sativa, and a complex mixture of bioactive terpenes naturally present in the same plant. **Cannabidiol** acts through multiple mechanisms including low-affinity agonism and negative allosteric modulation at CB1 and CB2 cannabinoid receptors, and interacts with a range of other molecular targets (e.g., TRPV1/2, adenosine A2A, GPR55, 5-HT1A). Cannabidiol is primarily recognized for its anticonvulsant, anti-inflammatory, anxiolytic, and potential antineoplastic properties[2][3]. The **bio-terpene complex** refers to a blend of naturally occurring terpenes such as \u03b1-humulene, \u03b2-pinene, linalool, geraniol, and \u03b2-caryophyllene, which are proposed to mimic or modulate cannabinoid effects partly via CB1, adenosine A2A, and possibly other GPCR targets, producing the so-called "entourage effect"[1]. Combinatorial use is hypothesized to enhance or modify the efficacy and side effect profile of cannabinoids through polypharmacology and synergistic actions at shared and distinct molecular targets[1][2]. This combination is not an approved pharmaceutical but may be marketed as a dietary supplement or medical cannabis formulation.